Two Sigma Securities LLC raised its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 120.2% during the first quarter, according to its most recent filing with the SEC. The fund owned 4,642 shares of the medical research company’s stock after buying an additional 2,534 shares during the period. Two Sigma Securities LLC’s holdings in Thermo Fisher Scientific were worth $713,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. BB&T Securities LLC boosted its stake in shares of Thermo Fisher Scientific by 4.4% in the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after buying an additional 3,819 shares during the period. Toronto Dominion Bank boosted its stake in shares of Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock worth $16,450,000 after buying an additional 37,307 shares during the period. Tompkins Financial Corp boosted its stake in shares of Thermo Fisher Scientific by 0.8% in the first quarter. Tompkins Financial Corp now owns 5,183 shares of the medical research company’s stock worth $733,000 after buying an additional 40 shares during the period. Huntington National Bank boosted its stake in shares of Thermo Fisher Scientific by 6.9% in the first quarter. Huntington National Bank now owns 186,907 shares of the medical research company’s stock worth $28,708,000 after buying an additional 12,025 shares during the period. Finally, Advisors Asset Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 1.1% in the first quarter. Advisors Asset Management Inc. now owns 66,308 shares of the medical research company’s stock worth $10,185,000 after buying an additional 735 shares during the period. Hedge funds and other institutional investors own 87.15% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded up 1.07% during trading on Friday, reaching $173.57. The company’s stock had a trading volume of 400,837 shares. The stock has a market capitalization of $67.71 billion, a PE ratio of 30.24 and a beta of 1.06. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87. The firm’s 50-day moving average is $176.85 and its 200-day moving average is $165.24.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period last year, the business posted $2.03 earnings per share. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: “Two Sigma Securities LLC Raises Position in Thermo Fisher Scientific Inc (NYSE:TMO)” was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.watchlistnews.com/two-sigma-securities-llc-raises-position-in-thermo-fisher-scientific-inc-nysetmo/1475498.html.

TMO has been the topic of a number of research reports. Cantor Fitzgerald initiated coverage on shares of Thermo Fisher Scientific in a report on Thursday, May 18th. They set an “overweight” rating and a $194.00 target price on the stock. Barclays PLC set a $175.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Wednesday, April 26th. Cowen and Company restated an “outperform” rating and set a $185.00 target price (up previously from $175.00) on shares of Thermo Fisher Scientific in a report on Saturday, April 29th. Citigroup Inc. restated a “buy” rating and set a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub upgraded shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. One investment analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and an average price target of $188.56.

In related news, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the transaction, the chief executive officer now directly owns 269,279 shares in the company, valued at $46,528,718.41. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total value of $805,773.44. Following the transaction, the insider now owns 29,200 shares of the company’s stock, valued at $5,018,896. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,188 shares of company stock valued at $4,702,223. 0.49% of the stock is owned by company insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.